TransCure bioServices is delighted to announce a strategic partnership with Preclina, a leading South Korean preclinical research company renowned for its expertise in inflammatory… Read More »New Partnership: TransCure bioServices and Preclina Inc Join Forces to Expand Collaboration
TransCure bioServices has recently developed new mouse models for studying cancer therapies against Acute myeloid leukemia (AML) in vivo. These mouse leukemia models represent… Read More »What Can We Do For You: New CDX Models for AML Studies
Archamps, December 14th, 2022 – Developed in collaboration with the pharmaceutical industry and academic institutes, BioVolume is the world’s first 3D imaging solution. It… Read More »TransCure bioServices Improves Its Services with 3D Tumor Imaging from Biovolume
Archamps, June 29th, 2022 – Cathay Capital announced its investment in TransCure bioServices, alongside the management team and Financière Arbevel. With this transaction, TransCure… Read More »TransCure bioServices Welcomes Cathay Capital to Accelerate Its Ambitious Growth
TransCure bioServices is proud to announce that our facility is now fully accredited by the AAALAC, a compelling achievement rewarding hard-work and dedication to… Read More »TransCure bioServices is AAALAC Accredited
We all know that 2021 will go into almost everyone’s history book as the vaccine year against the COVID-19 pandemic. It made us realize… Read More »Science VS Sars-Cov-2: Science Could Win
Our initial humanized liver mouse model (hu-PIRF) has now been fully validated in-house thanks to our collaboration with Professor Karl-Dimiter Bissig of Duke University… Read More »TransCure bioServices Launches Humanized Liver Mouse Model
State-of-the-Art and Expanded Animal Facilities at TransCure bioServices We have totally refurbished and remodeled our extended animal facility (now more than 500 m2 –… Read More »Brand New Rodent Animal Facility at TransCure bioServices
In mid-2020, our CSO Dr. Sebastien Tabruyn, PhD hosted our first webinar series focusing on our core expertises: immuno-oncology, inflammation and infectious disease, using… Read More »Webinar 2020 Series: Immuno-Oncology, IBD, and Infectious Diseases
At TransCure bioServices, we dedicate time and effort in supporting the preclinical development of our customers. We rely on our BSL-2 and BSL-3 rodent… Read More »Our Animal and Lab Facilities are Evolving
